Bay Street News, February, 2024

SOLANA BEACH, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, […]

Gilead Sciences, Inc. has proposed to acquire CymaBay for $32.50 per share in cash or a total equity value of […]

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture […]

MONTREAL and CHARLOTTE, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the […]

ROCKVILLE, Md., Feb. 28, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]

–   Revenues Increase 229% to a Record $388 Million in 2023–   Net Income Improves to $261.2 Million, or $1.06 per Diluted Share, […]

Wilmington, Delaware, Feb. 28, 2024 (GLOBE NEWSWIRE) — Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special […]

FREEHOLD, NJ, Feb. 28, 2024 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income of $220.9 million for […]

New York, NY, Feb. 28, 2024 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) senior management will present at the 2024 […]

PALM BEACH GARDENS, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) today announced that the Company […]